WebsiteGear Logo Log In
New User? Sign Up
About | Contact | FAQ
  Home News Web Hosting Domain Name Industry Tuesday, March 31, 2020 
Add Press Release News | News Feeds Feeds | Email This News Email


Outlook on the Global Prefilled Syringes Market (2020 to 2030) - Prefilled Syringes in Autoinjectors and Pen Injectors Presents Opportunities
Saturday, February 29, 2020

DUBLIN, Feb. 21, 2020 /PRNewswire/ -- The "Prefilled Syringes Market (5th Edition), 2020-2030" report has been added to ResearchAndMarkets.com's offering.

https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

This report features an extensive study of the current market landscape of prefilled syringes and the likely future opportunities associated with such devices, over the next 10-12 years. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain.

One of the key objectives of the report was to evaluate the current market size and the future opportunity within the prefilled syringes market. Based on various relevant parameters, such as the number of commercialized combination products, annual adoption rate, and expected pricing, the report provides an informed estimate of the likely evolution of the market over the period 2019-2030.

In order to provide a detailed future outlook, projections have been segmented on the basis of:

    1. Therapeutic area (autoimmune disorders, infectious diseases, neurological
       disorders, blood disorders, oncological disorders, psychiatric disorders,
       respiratory disorders, cardiovascular disorders, metabolic disorders,
       ophthalmic diseases, orthopedic disorders and others)
    2. Type of syringe
    3. Type of material (glass and plastic)
    4. Number of chambers (single chamber and dual chamber)
    5. Type of drug molecule (antibodies, proteins, vaccines, small molecules,
       peptides, and others), and
    6. Key geographies (North America, Europe (the UK, France, Italy, Spain,
       Germany and the rest of Europe), Latin America (Brazil, Mexico, Argentina
       and the rest of Latin America), Asia Pacific (Japan, China, India, South
       Korea and the rest of Asia Pacific), and the Middle East and Africa
       (Saudi Arabia, UAE, Africa and the rest of the Middle East))

In addition to other elements, the study includes:

    --  An overview of the current market landscape of companies engaged in
        manufacturing prefilled syringes, providing information on year of
        establishment, company size, geographical location of the headquarters
        and manufacturing facilities, type of material used (glass and plastic),
        number of barrel chambers (single chamber and dual chamber), type of
        needle system (fixed needle system, luer lock and luer cone) and syringe
        volume.
    --  An overview of the current market landscape of companies that are
        developing drugs in combination with prefilled syringes, featuring
        information on year of establishment, company size, geographical
        location of the developers, target therapeutic area, phases of
        development, type of drug molecule, route of administration, approval
        year (for marketed products), dosage details (for marketed products) and
        other approved dosage forms (for marketed products).
    --  A detailed competitiveness analysis of the various prefilled syringes
        that we came across, taking into consideration the supplier power (based
        on the employee size of developer/manufacturer and their respective
        annual revenues) and key product specifications, such as number of
        chambers in the barrel, number of needle systems, volume of the barrel,
        technological advancement/user-friendliness and other distinguishing
        features.
    --  A list of marketed drugs/therapies and pipeline candidates that are
        likely to be developed in combination with prefilled syringes in the
        near future, shortlisted based on an in-depth analysis that takes into
        consideration various relevant parameters, such as route of
        administration, type of drug molecule, target indications, other
        available dosage forms (for approved drugs) and historical annual sales
        information (for approved drugs).
    --  An analysis presenting potential strategic partners (primarily drug
        developers) for prefilled syringe manufacturers (with regard to likely
        collaboration opportunities for combination product development) based
        on different parameters, such as pipeline strength, target therapeutic
        indication(s) and developer strength.
    --  An analysis of the various prefilled syringe combination product-related
        initiatives of big pharma players, based on parameters, such as current
        adoption (based on number of approved and under development prefilled
        syringe combination products) and likely future adoption (based on
        potential injectable product candidates in the pipeline that are likely
        to be delivered via prefilled syringes), target therapeutic area(s) and
        type of drug molecule.
    --  A review of the landscape of contract fill/finish services providers
        that offer services for prefilled syringes, featuring a list of active
        (large-sized) service providers and analysis based on a number of
        relevant parameters, such as year of establishment, company size, scale
        of operation (preclinical, clinical and commercial), type of drug
        molecule (biologics and small molecules), and geographical location of
        the service provider.
    --  A detailed discussion on various safety features (add-on and integrated
        devices) installed in recent versions of prefilled syringes and the
        companies involved in developing and manufacturing such solutions.
    --  An informative summary of various guidelines established and issued by
        major regulatory bodies for the approval of prefilled syringes, across
        different countries/geographical regions.
    --  Brief discussions of currently available specialty syringes, which
        include prefilled flush syringes, prefilled diluent syringe systems and
        prefilled contrast agent delivery systems.
    --  A case study on companies that are engaged in the manufacturing of
        autoinjectors, featuring brief profiles of key players in this domain;
        each profile includes an overview of the firm, and information on its
        respective product portfolio.
    --  Elaborate profiles of prominent prefilled syringe manufacturers engaged
        in this domain, featuring a brief overview of the company, its financial
        information (if available), information on product portfolio, recent
        developments and an informed future outlook.
    --  Elaborate profiles of prominent prefilled syringe component
        manufacturers, featuring a brief overview of the company, its financial
        information (if available), information on product portfolio, recent
        developments and an informed future outlook.

Growth Drivers

    --  Rising Incidence of Chronic Diseases
    --  Growing Preference for Self-Injection
    --  Evolving Patient Demographics
    --  Growth of Biologics and Biosimilars Market
    --  Changing Pharmaceutical Strategies
    --  Increasing Focus on Prevention of Needlestick Injuries
    --  Prefilled Syringes in Autoinjectors and Pen Injectors

Companies Mentioned

    --  3D Medicines
    --  Abbott
    --  AbbVie
    --  Abivax
    --  Ablynx
    --  Acceleron Pharma
    --  Accord Healthcare
    --  Activa Brand Products
    --  Adamis Pharmaceuticals
    --  Adimmune
    --  Adocia
    --  Advance Pharma Lab
    --  Aerpio Therapeutics
    --  Affibody
    --  Agenus
    --  Aguettant
    --  Aijex Pharma International
    --  Ajinomoto Bio-Pharma Services
    --  Akeso Biopharma
    --  AKRA DERMOJET
    --  Akums Drugs & Pharmaceuticals
    --  Al Biosciences
    --  Alder BioPharmaceuticals
    --  Alexion
    --  Alfa Corpuscles
    --  Alfasigma
    --  Alkermes
    --  Allergan
    --  Alnylam Pharmaceuticals
    --  Alphamab Jilin
    --  Altor BioScience
    --  Alvogen
    --  Alvotech
    --  Alzheimer's Association
    --  AMAG Pharmaceuticals
    --  Amega Biotech
    --  Amgen
    --  AMRI
    --  AnaptysBio
    --  Andes Biotechnologies
    --  Antares Pharma
    --  Antev
    --  Apellis Pharmaceuticals
    --  APL (Apotek Produktion & Laboratorier)
    --  Apobiologix
    --  Aptar Pharma
    --  Aquabiliti
    --  Araclon Biotech
    --  Archivel Farma
    --  Arecor
    --  Arrowhead Pharmaceuticals
    --  Arte
    --  Asarina Pharma
    --  Ascendis Pharma
    --  ASIT biotech
    --  Assistance Publique Hpitaux de Paris
    --  Astellas Pharma
    --  AstraZeneca
    --  AV7
    --  Axon Neuroscience
    --  B. Braun Medical
    --  Bavarian Nordic
    --  Baxalta
    --  Baxter
    --  Bayer
    --  Becton Dickinson
    --  Bespak
    --  Beximco Pharma
    --  Biocad
    --  Biocon
    --  Biocorp
    --  Biogen
    --  BioGenCell
    --  Bioinova
    --  BioLineRx
    --  BioMarin Pharmaceutical
    --  BioMimetix
    --  BioPharma Solutions (a business unit of Baxter)
    --  BioValve Technologies
    --  BirgiMefar
    --  Boehringer Ingelheim
    --  Bone Therapeutics
    --  Boryung Pharmaceutical
    --  Boston Biomedical
    --  Boston Pharmaceuticals
    --  Bracco Diagnostics
    --  Braeburn Pharmaceuticals
    --  Bristol-Myers Squibb
    --  Brooklyn ImmunoTherapeutics
    --  Caladrius Biosciences
    --  Camurus
    --  CARBOGEN AMCIS
    --  Cardinal Health
    --  Catalent
    --  Catalyst Biosciences
    --  CeleCor Therapeutics
    --  Celgene
    --  Celldex Therapeutics
    --  Celltrion
    --  Cenexi
    --  Centrexion Therapeutics
    --  CinnaGen
    --  Ciron Drugs
    --  Civi Biopharma
    --  Coherus Biosciences
    --  Consort Medical
    --  Corden Pharma
    --  Corvidia Therapeutics
    --  Covidien
    --  Credence Medsystems
    --  CrossJect
    --  CSL Behring
    --  CSPC ZhongQi Pharmaceutical Technology
    --  CytoDyn
    --  Daewoong Pharmaceutical
    --  Daiichi Sankyo
    --  DALI Medical Devices
    --  Datwlyer
    --  Delpharm
    --  DiaMedica Therapeutics
    --  Dicerna Pharmaceuticals
    --  Dr. Reddy's Laboratory
    --  Dynavax Technologies
    --  E3D
    --  Eisai
    --  Elcam Medical
    --  Eli Lilly
    --  Eloxx Pharmaceuticals
    --  Emcure Pharmaceuticals
    --  EMD Serono
    --  Emergent BioSolutions
    --  Enzon Pharma
    --  Ever Pharma
    --  Excelsior Medical
    --  Ferring Pharmaceuticals
    --  Follicum
    --  Foresee Pharmaceutical
    --  Fresenius Kabi
    --  Fujifilm Kyowa Kirin Biologics
    --  Future Injection Technologies
    --  Galapagos
    --  GC Pharma
    --  GE Healthcare
    --  Genentech
    --  Generon (Shanghai)
    --  Genexine
    --  Genocea Biosciences
    --  Genzyme
    --  GERCOR
    --  Gerresheimer
    --  Getz Pharma
    --  Gland Pharma
    --  GSK
    --  Guerbet
    --  HAL Allergy
    --  Hanmi Pharmaceutical
    --  Harbour BioMed
    --  Haselmeier
    --  Healthcare Pharmaceuticals
    --  Helixmith
    --  Hengrui Yuanzheng Bio-Technology
    --  Heron Therapeutics
    --  Hetero Drugs
    --  Hexal
    --  IDT Biologika
    --  Iltoo Pharma
    --  Il-Yang Pharmaceutical
    --  Immune Response BioPharma
    --  ImmunoVaccine
    --  Immunovant Sciences
    --  Immutep Australia
    --  Injecto
    --  Injex
    --  Inmune Bio
    --  Innovent Biologics
    --  Inovio Pharmaceuticals
    --  Intas Pharmaceuticals
    --  Intron Biotechnology
    --  Ionis Pharmaceuticals
    --  Ipsen
    --  ISU Abxis
    --  Italfarmaco
    --  Izana Bioscience
    --  J.O. Pharma
    --  Janssen
    --  Jiangsu Hansoh Pharmaceutical
    --  Jiangsu HengRui Medicine
    --  Jiangsu Hualan Pharmaceutical New Material
    --  Jiangsu T-Mab Biopharma
    --  Jiangxi Sanxin Medtec
    --  Jinan Youlyy Industrial
    --  Johnson & Johnson
    --  Kaleo Pharma
    --  Kang Stem Biotech
    --  Kemwell Biopharma
    --  KeyBioscience
    --  Kezar Life Sciences
    --  Kiniksa Pharmaceuticals
    --  Kyowa Hakko Kirin
    --  La Jolla Pharmaceutical
    --  Laboratorios SALVAT
    --  LEO Pharma
    --  LG Chem
    --  LIB Therapeutics
    --  Lonstroff
    --  Lonza
    --  Lundbeck
    --  Luye Pharma
    --  M3 Biotechnology
    --  Mada Medical Products
    --  Mallinckrodt
    --  Medefil
    --  Medicago
    --  MedicalChain International
    --  Medigen Vaccine Biologics
    --  MedImmune
    --  MedPro Safety Products
    --  Medtronic
    --  MedxL
    --  Merck
    --  Merck Serono
    --  Meridian
    --  Merit Medical
    --  Mika Medical
    --  Millendo Therapeutics
    --  Millennium Pharmaceuticals
    --  Minervax
    --  miRagen Therapeutics
    --  Mithra Pharmaceuticals
    --  Mitsubishi Tanabe
    --  Modus Therapeutics
    --  Mologen
    --  Mylan
    --  Nektar Therapeutics
    --  Nemera
    --  NeoImmuneTech
    --  Neumedicines
    --  Neuraly
    --  NGM Biopharmaceuticals
    --  Ningbo Zhengli Pharmaceutical Packing
    --  NIPRO
    --  Nora Therapeutics
    --  Nordic Bioscience
    --  NovaDigm Therapeutics
    --  Novartis
    --  Novavax
    --  Novo Nordisk
    --  NPS Pharmaceuticals (a subsidiary of Shire)
    --  Nuance Designs
    --  Nurse Assist
    --  OBI Pharma
    --  OliPass
    --  Olix Pharmaceuticals
    --  Ology Bioservices
    --  Omeros
    --  Ompi
    --  Oncobiologics
    --  Oncolix
    --  OncoPep
    --  OncoTherapy Science
    --  Oncovir
    --  OPKO Health
    --  Optimum Medical
    --  Orphan Disease Treatment Institute
    --  Osivax
    --  Otsuka Pharmaceutical
    --  Oval Medical Technologies
    --  Owen Mumford
    --  PA Consulting
    --  Palatin Technologies
    --  Patheon
    --  PCI Pharma Services
    --  PegBio
    --  PenJet
    --  Pfizer
    --  Pfizer CentreOne
    --  PharmaJet
    --  PhaseBio Pharmaceuticals
    --  PHC Injection Device Technologies
    --  Piramal Enterprises
    --  Pisa Farmaceutica
    --  Plas-Tech Engineering
    --  Pluristem Therapeutics
    --  Polaris Group
    --  PRA Health Sciences
    --  Primequal
    --  ProJect Pharmaceutics
    --  Promius Pharma
    --  Protagonist Therapeutics
    --  Proteo Biotech
    --  Qilu Pharmaceutical
    --  Qu Biologics
    --  Quratis
    --  Ra Pharmaceuticals
    --  Rafa Laboratories
    --  Raumedic
    --  Regenera Pharma
    --  Regeneron
    --  Reliance Life Sciences
    --  REMD Biotherapeutics
    --  Rentschler Biopharma
    --  Retractable Technologies
    --  Revolutions Medical
    --  RHEACELL
    --  Rhythm Pharmaceuticals
    --  Roche
    --  Roselabs biosciences
    --  Rovi Pharmaceutical
    --  R-Pharm
    --  Samsung Bioepis
    --  Samsung Biologics
    --  Sandoz
    --  Sanofi
    --  SCHERDEL Medtec
    --  Schering Medipharm
    --  Schott
    --  Schott-Kaisha
    --  Seqirus
    --  Serina Therapeutics
    --  Shandong Pharmaceutical Glass
    --  Shandong Weigao
    --  Shandong Zibo Minkang Pharmaceutical Packing
    --  Shanghai Biomabs Pharmaceutical
    --  Shenyang Sunshine Pharmaceutical
    --  Shin Yan Sheno Precision Industrial
    --  Shire
    --  SHL Group
    --  Siegfried Holding
    --  Sinocelltech
    --  SiO2 Medical Products
    --  Smiths Medical
    --  Swedish Orphan Biovitrum (SOBI)
    --  Spectrum Pharmaceuticals
    --  Splash Pharmaceuticals
    --  Square Pharmaceuticals
    --  SRI International
    --  Stealth BioTherapeutics
    --  Sun BioPharma
    --  Sun Pharma
    --  Suzuken
    --  SynDevRx
    --  Synermore Biologics
    --  Taisei Kako
    --  Takeda
    --  Terumo Europe
    --  Teva Pharmaceutical
    --  The Medical House
    --  The Medicines Company
    --  The National Medical Products
    --  Themis Bioscience
    --  Therachon
    --  TikoMed
    --  Tip-Top
    --  Tolmar
    --  Transcoject
    --  Transgene
    --  Troikaa
    --  Turnstone Biologics
    --  Tyfill Pharmapack
    --  UCB Biopharma
    --  Union Medico
    --  United Neuroscience
    --  US Medical Instruments
    --  Vaccibody
    --  Vaccitech
    --  Valeant Pharmaceutical
    --  Valeritas
    --  Valneva
    --  Vaxine
    --  Vetter Pharma
    --  Viela Bio
    --  ViiV Healthcare
    --  Vir Biotechnology
    --  Viriom
    --  Vitaeris
    --  VLP Therapeutics
    --  West Pharmaceutical
    --  Xbiotech
    --  XEME Biopharma
    --  YangZhong Wealth Metal
    --  YL Biologics
    --  Ypsomed
    --  Zealand Pharma
    --  Zhejiang Huahai Pharmaceutical
    --  Zogenix
    --  ZymoGenetics

For more information about this report visit https://www.researchandmarkets.com/r/46ep1

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/outlook-on-the-global-prefilled-syringes-market-2020-to-2030---prefilled-syringes-in-autoinjectors-and-pen-injectors-presents-opportunities-301009054.html

SOURCE Research and Markets



Email This News Email | Submit To Slashdot Slashdot | Submit To Digg.com Digg | Submit To del.icio.us Del.icio.us | News Feeds Feeds

RELATED NEWS ARTICLES
Nav Informatica Launches New Intelligence and Automation Innovations Across the Intelligent Data Platform | Mar 31, 2020
Nav Global Combined Heat & Power Industry | Mar 31, 2020
Nav Microservices Architecture Market to Reach $8.07 Bn, Globally, by 2026 at 18.6% CAGR: Allied Market Research | Mar 31, 2020
Nav With Recession Looming, the Three Biggest Mistakes Procurement & Supply Chain Leaders Must Avoid | Mar 31, 2020
Nav Outlook into the Worldwide Oral Vaccine Market to 2025 - Featuring GlaxoSmithKline, PaxVax and Shanghai BravoBio Among Others | Mar 31, 2020
Nav Global CMOS Image Sensor Industry | Mar 31, 2020
Nav Global COVID-19 (Coronavirus) Pipeline Scenario & Growth Prospects, 2020 - Analysis by Development Stage, Mechanism of Action, Route of Administration and Molecule Type | Mar 31, 2020
Nav 2020 Pipeline Insight on Insulin Resistance | Mar 31, 2020
Nav Global docking station market is expected to grow with a CAGR of 6% over the forecast period from 2019-2025 | Mar 31, 2020
Nav Global diet soft drinks market is expected to grow with a CAGR of 4% over the forecast period from 2019-2025 | Mar 31, 2020
NEWS SEARCH

FEATURED NEWS | POPULAR NEWS
Submit News | View More News View More News